Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v24-EN | Version v10-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2022-10-13 | 2022-08-19 |
| Drug Identification Number | 00893285 | 00893285 |
| Brand name | NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP | NOREPINEPHRINE BITARTRATE INJ 1MG/ML USP |
| Common or Proper name | NOREPINEPHRINE | NOREPINEPHRINE |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | NOREPINEPHRINE | NOREPINEPHRINE |
| Strength(s) | 1MG | 1MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 4ML 10LIV | 4ML 10LIV |
| ATC code | C01CA | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2022-08-18 | |
| Actual start date | 2022-09-27 | |
| Estimated end date | 2022-10-21 | Unknown |
| Actual end date | 2022-10-12 | |
| Shortage status | Resolved | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Product is available on allocation at wholesalers, based on 100% of historical volumes. | Product is available on allocation at wholesalers, based on 100% of historical volumes. |
| Health Canada comments |